Skip to main content

Advertisement

Table 1 Clinical characteristics and first-line treatment modalities

From: Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement

  No. of patients (%) n = 75 (100)
Median age [range], years 54 [16–83]
Sex
 Men  Women 51 (68) 24 (32)
Ann Arbor stage
 IE-IIE  IIIE-IVE  B symptoms 34 (45) 41 (55) 26 (35)
LDH
 Elevated  Normal  Missing 41 (56) 32 (44) 2
ECOG
 0–1   > 1  Missing 50 (72) 19 (28) 6
No. of extranodal sites
 1  2  3   > 3 24 (32) 30 (40) 13 (17) 8 (11)
Calcium
 Elevated  Normal  Missing 6 (9) 62 (91) 7
AP
 Elevated  Normal  Missing 14 (22) 50 (78) 11
Skeletal involvement
 Unifocal  Multifocal 45 (60) 30 (40)
Chemotherapy
 Palliative  CHOP  more intensive than CHOP 2 (3) 46 (61) 27 (36)
Rituximab 60 (80)
Radiotherapy 37 (49)
CNS treatment 20 (27)
Autologous transplantation 6 (8)